NFKB1 and cancer: This therapeutic strategy will be better tolerated as it will not block all NF-κB housekeeping functions in all cell types and will instead only block a subset of NF-κB genes, regulated by LOC/Gm16685, in a cell-type-specific manner (cancer cells and GAMs).